A new VGLUT-specific potent inhibitor: Pharmacophore of brilliant yellow

Neurochemical Research

Volumn 39, Issue 1, 2014, Pages 117-128

  Tamura, Yutaka ^a,b   Ogita, Kiyokazu ^a,c   Ueda, Tetsufumi ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b FUKUYAMA UNIVERSITY   (Japan)

^c SETSUNAN UNIVERSITY   (Japan)

Author keywords

Brilliant Yellow; Glutamate uptake; Inhibitor; Pharmacophore; Synaptic vesicles

Indexed keywords

4 AMINOBUTYRIC ACID; BRILLIANT BLUE; BRILLIANT YELLOW; DYE; GLUTAMIC ACID; PROTEIN INHIBITOR; TRYPAN BLUE; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER; VESICULAR GLUTAMATE TRANSPORTER INHIBITOR;

4 AMINOBUTYRIC ACID UPTAKE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; IC 50; MOLECULAR MODEL; NONHUMAN; PHARMACOPHORE; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION; SYNAPSE VESICLE; SYNAPTOSOME;

ANIMALS; APRAXIA, IDEOMOTOR; AZO COMPOUNDS; BENZENESULFONATES; CATTLE; DIARYLHEPTANOIDS; GLUTAMIC ACID; INDOLES; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; SYNAPTIC VESICLES; VESICULAR GLUTAMATE TRANSPORT PROTEINS;

EID: 84892679308     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-013-1196-8     Document Type: Article

References (58)

1. Naito S, Ueda T (1983) Adenosine triphosphate-dependent uptake of glutamate into protein I associated synaptic vesicles. J Biol Chem 258:696-699 (Pubitemid 13139315)
2. Naito S, Ueda T (1985) Characterization of glutamate uptake into synaptic vesicles. J Neurochem 44:99-109 (Pubitemid 15190740)
3. Maycox PR, Deckwerth T, Hell JW, Jahn R (1988) Glutamate uptake by brain synaptic vesicles. Energy dependence of transport and functional reconstitution in proteoliposomes. J Biol Chem 263:15423-15428
4. Fykse EM, Christensen H, Fonnum F (1989) Comparison of the properties of γ-aminobutyric acid and L-glutamate uptake into synaptic vesicles isolated from rat brain. J Neurochem 52:946-951 (Pubitemid 19067558)
5. Tabb JS, Ueda T (1991) Phylogenetic studies on the synaptic vesicle glutamate transport system. J Neurosci 11:1822-1828
6. Tabb JS, Kish PE, Van Dyke R, Ueda T (1992) Glutamate transport into synaptic vesicles. Roles of membrane potential, pH gradient, and intravesicular pH. J Biol Chem 267:15412-15418
7. Wolosker H, de Souza DO, de Meis L (1996) Regulation of glutamate transport into synaptic vesicles by chloride and proton gradient. J Biol Chem 271:11726-11731 (Pubitemid 26157241)
8. Özkan ED, Ueda T (1998) Glutamate transport and storage in synaptic vesicles. Jpn J Pharmacol 77:1-10 (Pubitemid 28263985)
9. Bellocchio EE, Reimer RJ, Fremeau RTJ, Edwards RH (2000) Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. Science 289:957-960 (Pubitemid 30659949)
10. Takamori S, Rhee JS, Rosenmund C, Jahn R (2000) Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature 407:189-194
11. Fremeau RT Jr, Voglmaier S, Seal RP, Edwards RH (2004) VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate. Trends Neurosci 27:98-103 (Pubitemid 38167332)
12. Erickson JD, De Gois S, Varoqui H, Schafer MKH, Weihe E (2006) Activity-dependent regulation of vesicular glutamate and GABA transporters: a means to scale quantal size. Neurochem Int 48:643-649
13. Wilson NR, Kang J, Hueske EV, Leung T, Varoqui H, Murnick JG, Erickson JD, Liu G (2005) Presynaptic regulation of quantal size by VGLUT1. J Neurosci 25:6221-6234 (Pubitemid 40923489)
14. Van der Hel W et al (2009) Hippocampal distribution of vesicular glutamate transporter 1 in patients with temporal lobe epilepsy. Epilepsia 50:1717-1728
15. Kang T-C, Kim D-S, Kwak S-E, Kim J-E, Kim DW, Kang JH, Won MH, Kwon O-S, Choi S-Y (2005) Valproic acid reduces enhanced vesicular glutamate transporter immunoreactivities in the dentate gyrus of the seizure prone gerbil. Neuropharmacology 49:912-921 (Pubitemid 41483897)
16. Kim J-E et al (2007) Anti-glutamatergic efect of rizuzole: comparison with valoproic acid. Neuroscience 147:136-145 (Pubitemid 46873852)
17. Touret M, Parrot S, Denoroy L, Belin M-F, Didier-Bazes M (2007) Glutamatergic alterations in the cortex of genetic absence epilepsy rats. BMC Neurosci 8:69-76 (Pubitemid 47559935)
18. Lewis SM, Lee FS, Todorova M, Seyfried TN, Ueda T (1997) Synaptic vesicle glutamate uptake in epileptic (EL) mice. Neurochem Int 31:581-585 (Pubitemid 27375868)
19. Varea E, Guirado R, Gilabert-Juan J, Marti U, Castillo-Gomez E, Blasco-Ibanez JM, Crespo C, Nacher J (2012) Expression of PSA-NCAM and synaptic proteins in the amygdala of psychiatric disorder patients. J Psychiatr Res 46:189-197
20. Winter HC, Ueda T (1993) Glutamate uptake system in the presynapric vesicle: glutamic acid analogs as inhibitors and alternative substrates. Neurochem Res 18:79-85 (Pubitemid 23006987)
21. Winter HC, Ueda T (2008) The glutamate uptake system in presynaptic vesicles: further characterization of structural requirements for inhibitors and substrates. Neurochem Res 33:223-231
22. Moriyama Y, Yamamoto A (1995) Vesicular L-glutamate transporter in microvesicles from bovine pineal glands. Driving force, mechanism of chloride anion activation, and substrate specificity. J Biol Chem 270:22314-22320
23. Bartlett RD, Esslinger CS, Thompson CM, Bridges RJ (1998) Substituted quinolines as inhibitors of L-glutamate transport into synaptic vesicles. Neuropharmacology 37:839-846 (Pubitemid 28375751)
24. Thompson CM, Davis E, Carrigan CN, Cox HD, Bridges RJ, Gerdes JM (2005) Inhibitors of the glutamate vesicular transporter (VGLUT). Curr Med Chem 12:2041-2056 (Pubitemid 41086747)
25. Roseth S, Fykse EM, Fonnum F (1998) Uptake of Lglutamate into synaptic vesicles: competitive inhibition by dyes with biphenyl and amino and sulphonic acid substituted naphthyl groups. Biochem Pharmacol 56:1243-1249 (Pubitemid 28512676)
26. Fonnum F, Fykse EM, Roseth S (1998) Uptake of glutamate into synaptic vesicles. Prog Brain Res 116:87-101
27. Roseth S, Fykse EM, Fonnum F (1995) Uptake of L-glutamate into rat brain synaptic vesicles: effect of inhibitors that bind specifically to the glutamate transporter. J Neurochem 65:96-103
28. Özkan ED, Lee FS, Ueda T (1997) A protein factor that inhibits ATP-dependent glutamate and γ-aminobutyric acid accumulation into synaptic vesicles: purification and initial characterization. Proc Natl Acad Sci USA 94:4137-4142 (Pubitemid 27180512)
29. Ogita K, Hirata K, Bole DG, Yoshida S, Tamura Y, Leckenby AM, Ueda T (2001) Inhibition of vesicular glutamate storage and exocytotic release by Rose Bengal. J Neurochem 77:34-42 (Pubitemid 32245077)
30. Bole DG, Ueda T (2005) Inhibition of vesicular uptake by Rose Bengal-related compounds: structure activity relationship. Neurochem Res 30:363-369 (Pubitemid 40880812)
31. Patel SA, Nagy JO, Bolstad ED, Gerdes JM, Thompson CM (2007) Tetrapeptide inhibitors of the glutamate vesicular transporter (VGLUT). Bioorg Med Chem Lett 17:5125-5128 (Pubitemid 47259662)
32. Kish PE, Ueda T (1989) Glutamate accumulation into synaptic vesicles. Meth Enzymol 174:9-25 (Pubitemid 20046277)
33. Krueger BK, Forn J, Greengard P (1977) Depolarization-induced phosphorylation of specific proteins, mediated by calcium ion flux, in rat brain synaptosomes. J Biol Chem 252:2764-2773 (Pubitemid 8094127)
34. Allinger NL, Yeh YH, Lii J-H (1989) Molecular mechanics. The MM3 force field for hydrocarbons. J Am Chem Soc 111:8551-8556 (Pubitemid 20021795)
35. Sun G, Fronczek FR, Gandour RD (1993) (R)-2-hydroxy-3-iodo-2-methylpropyl 4-nitrobenzenesulfonate. Acta Crystallogr. C49:1507-1509
36. Sun G, Fronczek FR, Gandour RD (1995) Methyl (2S,6S:2R,6R)-6-(2- cyanoethyl)-4,6-dimethyl-2-morpholineacetate. Acta Crystallogr C51:980-982
37. Karunakaran V, Ramamurthy P, Josephrajan T, Ramakrishnan VT (2002) Solvent effects and photophysical studies of a new class of acridine(1,8)dione dyes. Spectrochim Acta A Mol Biomol Spectrosc 58:1443-1451 (Pubitemid 34466984)
38. Hay BP, Oliferenko AA, Uddin J, Zhang CG, Firman TK (2005) Search for improved host architectures: application of de novo structure-based design and high-throughput screening methods to identify optimal building blocks for multidentate ethers. J Am Chem 127:17043-17053 (Pubitemid 41772865)
39. Vukovic S, Hay BP (2013) De novo structure-based design of bis-amidoxime uranophiles. Inorg Chem 52:7805-7810
40. Lobur AT, Kish PE, Ueda T (1990) Synaptic vesicular glutamate uptake: modulation by a synaptosomal cytosolic factor. J Neurochem 54:1614-1618
41. 2+-dependent, evoked release of glutamate, GABA and serotonin. J Neurochem 76:1153-1164 (Pubitemid 32167389)
42. Kirschner N (1962) Uptake of catecholamines by a particulate fraction of the adrenal medulla. J Biol Chem 237:2311-2317
43. Johnson RG Jr (1988) Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport. Physiol Rev 68:232-307 (Pubitemid 18035237)
44. 3H] dihydrotetrabenazine. Proc Natl Acad Sci USA 80:584-588 (Pubitemid 13174647)
45. Stern-Bach Y, Greenberg-Ofrath N, Flechner I, Schuldiner S (1990) Identification and purification of a functional amine transporter from bovine chromaffin granules. J Biol Chem 265:3961-3966
46. + toxicity encodes a vesicular amine transporter. Cell 70:539-551
47. Erickson JD, Eiden LE, Hoffman B (1992) Expression cloning of a reserpine-sensitive monoamine transporter. Proc Natl Acad Sci USA 89:10993-10997
48. Schuldiner S, Shirvan A, Linial M (1996) Vesicular neurotransmitter transporters: from bacteria to humans. Physiol Rev 75:369-392
49. Erickson JD, Schafer MKH, Bonner TI, Eiden LE, Weihe E (1996) Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci USA 93:5166-5171 (Pubitemid 26162890)
50. Wimalasena K (2011) Vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistry. Med Res Rev 31:483-519
51. 11C]tetrabenazine and positron emission tomography. J Neurochem 60:2315-2318 (Pubitemid 23148808)
52. Frey KA, Koeppe RA, Kilbourn MR, Vander Borght TM, Albin RL, Gilman S, Kuhl DE (1996) Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Ann Neurol 40:873-884 (Pubitemid 27044605)
53. Ondo WG, Tintner R, Thomas M, Jankovic J (2002) Tetrabenazine treatment for Huntington's disease associated chorea. Clin Neuropharmacol 25:300-302 (Pubitemid 36025267)
54. Marshall FJ, Walker F, Frank S, Oakes D, Plumb S, Factor SA, Fahn S, Hunt VP, Jankovic J, Shinaman A, Shoulson I (2006) Tetrabenazine as antichorea therapy in Huntington's disease: a randomized controlled trial. Neurology 66:366-372 (Pubitemid 43739938)
55. Parsons SM, Prior C, Marshall IG (1993) Acetylcholine transport, storage, and release. Int Rev Neurobiol 35:279-390
56. Bahr BA, Clarkson ED, Rogers GA, Noremberg K, Prsons SM (1992) A kinetic and allosteric model for the acetylcholine transporter-vesamicol receptor in synaptic vesicles. Biochemistry 31:5752-5762
57. Giboureau N, Som IM, Boucher-Arnold A, Guilloteau D, Kassiou M (2010) PET radioligands for the vesicular acetylcholine transporter (VAChT). Curr Top Med Chem 15:1569-1583
58. Juge N, Yoshida Y, Yatsushiro S, Omote H, Moriyama Y (2006) Vesicular glutamate transporter contains two independent transport machineries. J Biol Chem 281:39499-39506 (Pubitemid 46041910)